Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Scleroderma, Systemic

abstract

  • Clinicaltrials.gov NCT01284322.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4563675

Digital Object Identifier (DOI)

  • 10.1172/JCI77958

PubMed ID

  • 26098215

Additional Document Info

start page

  • 2795

end page

  • 807

volume

  • 125

number

  • 7